Search

agbiopro
- Aug 3, 2020
- 0 min read

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

Recent Posts

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership